Search
for
Sort by
Research 30 of 86
- 320 An open label clinical trial of Abatacept (CTLA4-Ig) for alopecia areata
- Functional Interpretation of Genome-Wide Association Study Evidence in Alopecia Areata
- Emerging treatments in alopecia
- The Changing Landscape of Alopecia Areata: The Translational Landscape
- ACTH as first line treatment for acute calcium pyrophosphate crystal arthritis in 14 hospitalized patients
- Novel therapies for alopecia areata: The era of rational drug development
- Hair-cycle changes in two patients taking tocilizumab
- Current and future pharmacotherapy for alopecia areata
- Cytokine-targeted treatment in alopecia areata - new possibilities?
- Systemic Therapies for Scarring and Non-scarring Alopecia
- Immune Cell-Targeting Biologics for Alopecia Areata: A New Paradigm in Precision Medicine
- An Updated in the Management of Alopecia Areata
- 706 Predictive modeling of patient response to JAK/STAT inhibitors and dynamic patient-matching
- 397 Predictive modeling of drug response and mechanism of action in alopecia areata clinical trials
- Adverse Effects and Drug Interactions of Biologic Agents
- Proceedings of the 7thworld congress of hair research
- Limited Effectiveness of Platelet-Rich-Plasma Treatment on Chronic Severe Alopecia Areata
- Anticonvulsant hypocalcaemia.
- Reporting on Adverse Clinical Events
- The Genetic Architecture of Alopecia Areata
- Social media for arthritis-related comparative effectiveness and safety research and the impact of direct-to-consumer advertising
- New developments in the treatment of systemic lupus erythematosus
- BH17 Bridging the gap: identifying dual-targeting therapies for patients with alopecia areata and coexisting immune-mediated inflammatory diseases
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Alopecia areata: An update
- The role of lymphocytes in the development and treatment of alopecia areata
- Treatment options for alopecia: an update, looking to the future
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Ottawa, Ontario, Canada, February 13–16, 2013